piracetam has been researched along with haloperidol in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 4 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Ulbricht, B | 1 |
| Emilien, G | 1 |
| Bourin, M; Larousse, C; Poisson, L | 1 |
| Niss, AI; Trubkovich, MIa | 1 |
| Apud, JA; Masotto, C; Racagni, G | 1 |
| Allikmets, LH; Rägo, LK; Zarkovsky, AM | 1 |
| Margova, L; Toreva, D; Yonchev, A; Yonchev, V | 1 |
| Akhondzadeh, S; Amini-Nooshabadi, H; Davari-Ashtiani, R; Noorbala, AA | 1 |
| Dahmen, N; Eicke, M; Fehr, C; Klawe, C; Szegedi, A | 1 |
| Karakatsanis, NA; Karapoulios, E; Kouzoupis, AV; Masdrakis, VG; Oulis, P; Papadimitriou, GN; Papageorgiou, C; Soldatos, CR | 1 |
| Amabile, GA; Giacomini, P; Marchione, P; Marianetti, M; Romeo, T; Vento, C | 1 |
| Rosini, JM; Whyte, CJ | 1 |
2 trial(s) available for piracetam and haloperidol
| Article | Year |
|---|---|
[Clinical use of piracetam in chronic alcoholism and its complications predelirium and delirium].
Topics: Alcohol Withdrawal Delirium; Alcoholism; Clinical Trials as Topic; Drug Therapy, Combination; Haloperidol; Humans; Injections, Intravenous; Piracetam; Psychoses, Alcoholic; Pyrrolidinones | 1976 |
Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Nootropic Agents; Piracetam; Placebos; Psychiatric Status Rating Scales; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 1999 |
14 other study(ies) available for piracetam and haloperidol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effect of drugs acting on monoaminergic and cholinergic systems on the quantified EEG of rats.
Topics: Animals; Cerebral Cortex; Clonidine; Dose-Response Relationship, Drug; Electroencephalography; Evoked Potentials; Haloperidol; Locus Coeruleus; Male; Physostigmine; Piracetam; Psychotropic Drugs; Rats; Receptors, Adrenergic, alpha; Receptors, Cholinergic; Yohimbine | 1989 |
Piracetam interactions with neuroleptics in psychopharmacological tests.
Topics: Amphetamines; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Drug Interactions; Fluphenazine; Haloperidol; Hypothermia; Male; Mice; Piracetam; Pyrrolidinones; Sulpiride | 1986 |
[Various rarely encountered adverse effects and complications of psychopharmacotherapy].
Topics: Adult; Agnosia; Amitriptyline; Apraxias; Brain Diseases; Cerebral Cortex; Haloperidol; Humans; Male; Perceptual Disorders; Peripheral Nervous System Diseases; Piracetam; Psychotropic Drugs; Quadriplegia | 1985 |
Neurochemical studies on GABAergic and aminergic systems in the rat brain following acute and chronic piracetam administration.
Topics: Animals; Binding Sites; Brain Chemistry; Cerebellum; Cyclic GMP; Haloperidol; Learning; Male; Norepinephrine; Phospholipids; Piracetam; Prolactin; Pyrrolidinones; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Dopamine; Receptors, GABA-A; Receptors, Serotonin | 1985 |
Effects of piracetam on the central dopaminergic transmission.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; In Vitro Techniques; Piracetam; Pyrrolidinones; Rats; Synaptic Transmission | 1981 |
The effect of some neurotropic drugs on neuroleptic hypersensitivity of dopamine receptors in the central nervous system.
Topics: Adenosine Triphosphate; Animals; Apomorphine; Corpus Striatum; Cyclophosphamide; Drug Hypersensitivity; Dyskinesia, Drug-Induced; Haloperidol; Imipramine; Male; Parasympatholytics; Piracetam; Rats; Receptors, Dopamine; Trihexyphenidyl | 1980 |
Piracetam in the treatment of tardive dyskinesia and akathisia: a case report.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Neuroprotective Agents; Piracetam; Schizophrenia | 2001 |
Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome.
Topics: Adrenergic alpha-Agonists; Adult; Anti-Dyskinesia Agents; Anticonvulsants; Antipsychotic Agents; Clonidine; Drug Resistance; Female; Haloperidol; Humans; Levetiracetam; Pimozide; Piracetam; Tourette Syndrome; Treatment Outcome | 2008 |
Hemiballismus in subthalamic haemorrhage: efficacy of levetiracetam.
Topics: Aged; Anti-Dyskinesia Agents; Anticonvulsants; Antihypertensive Agents; Ataxia; Cerebellum; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesias; Haloperidol; Hemangioma, Cavernous, Central Nervous System; Humans; Hypertension; Intracranial Hemorrhage, Hypertensive; Levetiracetam; Lorazepam; Magnetic Resonance Imaging; Male; Piracetam; Recurrence; Subthalamic Nucleus; Treatment Outcome; Vomiting | 2009 |
Dantrolene for Treatment of Suspected Neuroleptic Malignant Syndrome.
Topics: Analgesics, Opioid; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Dantrolene; Diagnosis, Differential; Fentanyl; Haloperidol; Humans; Levetiracetam; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Phenytoin; Piracetam | 2018 |